Overview of interventions under VCAG review
Video
The WHO evaluation process for new interventions
This video provides a high-level overview of the WHO vector control evaluation process to evaluate new tools, strategies and approaches that combat vector-borne diseases, and the evidence that underpins an intervention’s safety, quality, entomological efficacy and public health value. It describes how a new tool enters the process, what pathway(s) the intervention must take as part of its evaluation, and the anticipated outcome of the respective pathways.
/in-page-highlights/vector-control-pathway-video.tmb-549v.jpg?sfvrsn=7098317a_6)
New tools, technologies and approaches
Operational procedures
All entities seeking WHO prequalification of vector control tools, technologies and approaches for public health are invited to submit a “Request for Determination of Pathway” form to pqvectorcontrol@who.int. WHO will use this form to determine the WHO evaluation pathway. For tools, technologies and approaches not covered by WHO policy recommendations, the applicant will then be contacted by the VCAG secretariat.
Reports
All →
Experts from the WHO Vector Control Advisory Group (VCAG) met with product developers, innovators and researchers from 25–28 March 2024 for the 20th...
Nineteenth meeting of the WHO Vector Control Advisory Group
Experts from the WHO Vector Control Advisory Group (VCAG) met with product developers, innovators and researchers from 27–28 September 2023 for the...
Experts from the WHO Vector Control Advisory Group (VCAG) met in a virtual meeting with product developers, innovators and researchers from 24–26...
Guidance
Preferred product characteristics (PPCs) are key tools to incentivize and guide the development of urgently needed health products. This PPC was developed...
"Preferred product characteristics" (PPCs) are key tools to incentivize and guide the development of urgently needed health products. This and other...
Indoor residual surface treatments for malaria transmission control in areas with insecticide-resistant...
"Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The WHO categorization...
Insecticide-treated nets for malaria transmission control in areas with insecticide-resistant mosquito...
“Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPC...
Vector control interventions designed to control malaria in complex humanitarian emergencies and in response...
“Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. Some...
Norms, standards and processes underpinning development of WHO recommendations on vector control
Vector-borne diseases (VBDs) result in high levels of morbidity and mortality, and disproportionately affect some of the world's poorest populations. However,...
Ethics and vector-borne diseases
Vector-borne diseases (VBDs) are a major contributor to global morbidity and mortality and have a disproportionate impact on the world’s poorest...
Evaluation of genetically modified mosquitoes for the control of vector-borne diseases
Vector-borne diseases (VBDs) cause more than 700 000 deaths annually and are responsible for 17% of the global burden of communicable diseases. Significant...
Data requirements and protocol for determining non-inferiority of insecticide-treated net and indoor...
The aim of this protocol is to support the generation of entomological data to inform a decision as to whether a candidate insecticide-treated net or indoor...
Ethical issues associated with vector borne diseases
In February 2017, the Global Health Ethics Unit hosted a scoping meeting which seeked to lay the groundwork for a guidance document on the ethical issues...
Feature stories
All →Related heath topics